Avricore Health (AVCRF) Capital Expenditures (2015 - 2025)
Avricore Health (AVCRF) reported Capital Expenditures of -$61285.8 for Q3 2025, up 52.43% year-over-year from -$40205.8 in Q3 2024, and down 23.82% quarter-over-quarter from -$49497.2 in Q2 2025.
Avricore Health (AVCRF) Capital Expenditures (2015 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 8 years of Capital Expenditures data on file, last reported at -$61285.8 in Q3 2025.
- Capital Expenditures for Q3 2025 came in at -$61285.8, up 52.43% year-over-year; the trailing twelve-month figure through Sep 2025 was -$286182.4 (up 44.66% YoY), and the FY2025 annual result was -$63339.2, up 52.11% from the prior year.
- Capital Expenditures fell to -$61285.8 in Q3 2025 per AVCRF's latest filing, from -$49497.2 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.4 million in Q4 2022 and troughed at -$465996.9 in Q3 2022.
- A 5-year average of -$7490.2 and a median of -$59072.5 in 2025 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 789.45% in 2022 and fell as far as 926.92% in 2022.
- A 5-year view of Capital Expenditures shows it stood at $162130.9 in 2021, then soared by 789.45% to $1.4 million in 2022, then sank by 117.49% to -$252185.1 in 2023, then surged by 48.91% to -$128834.1 in 2024, then surged by 52.43% to -$61285.8 in 2025.
- Business Quant data shows AVCRF's Capital Expenditures at -$61285.8 in Q3 2025, -$49497.2 in Q2 2025, and -$46565.2 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 39.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 376.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 237.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 8.27 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 76.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 22.14 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 127.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 38.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 17.41 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -61,285.85 |
| Sep 30, 2025 | -61,285.85 |
| Jun 30, 2025 | -49,497.21 |
| Jun 30, 2025 | -49,497.21 |
| Mar 31, 2025 | -46,565.17 |
| Mar 31, 2025 | -46,565.17 |
| Sep 30, 2024 | -128,834.14 |
| Sep 30, 2024 | -128,834.14 |
| Jun 30, 2024 | -79,225.66 |
| Jun 30, 2024 | -79,225.66 |
| Mar 31, 2024 | -56,859.23 |
| Mar 31, 2024 | -56,859.23 |
| Dec 31, 2023 | -252,185.14 |
| Dec 31, 2023 | -252,185.14 |
| Sep 30, 2023 | -199,343.20 |
| Sep 30, 2023 | -199,343.20 |
| Jun 30, 2023 | -139,598.98 |
| Jun 30, 2023 | -139,598.98 |
| Mar 31, 2023 | -165,311.04 |
| Mar 31, 2023 | -165,311.04 |